2010.05.06 Weekly Broadcast Email
The following updates were made to the CCCWFU CCOP Research Base website for the week of May 3, 2010.
The following adverse events were reported during the month of April
97405: 12 & 13
In the month of April, 15 patients were accrued to CCCWFU CCOP Research Base trials. Ochsner Clinic Foundation and CTSU were tied for the top accruing site with 4 patients each. See the Research Base website <http://www1.wfubmc.edu/cancer/Researchbase/> spotlight section for further information.
The results from several recently closed Research Base studies have been accepted for presentation at ASCO (June 4-8, 2010). Those studies include:
97202: Randomized Double-Blind Placebo-Controlled Study of Oral Coenzyme Q10 to Relieve Self-Reported Cancer Treatment Related Fatigue in Breast Cancer Patients
98308: A Phase III Randomized, Double-Blind, Placebo Controlled Trial of North American Ginseng Extract (CVT-E002;COLD-FX®) to Prevent Respiratory Infection and Reduce Antibiotic Use in Patients with Chronic Lymphocytic Leukemia.
Congratulations to those study PIs
Sarah Hahne will be out of the office on maternity leave through June 9. Please contact Lisa Autry Hawkins at email@example.com (336/716-0891)in her absence.